David Philpott is an Associate, Investment Banking at Bloom Burton & Co. In this role, he is responsible for conducting comprehensive due diligence, providing strategic advisory services, and scientific transactional support for biotechnology and healthcare companies. David joined the company as an Analyst in March 2023.
David completed his PhD in Engineering from the University of Toronto under the supervision of Shana Kelley. His doctoral research focused on developing high throughput microfluidic tools for functional genomics and antibody discovery. During his studies, David was a Vanier scholar and a fellow at Amplitude Ventures and Flagship Pioneering. David holds a BEng in Engineering Physics from McMaster University.
